You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AXID AR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Axid Ar, and when can generic versions of Axid Ar launch?

Axid Ar is a drug marketed by Haleon Us Holdings and is included in one NDA.

The generic ingredient in AXID AR is nizatidine. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nizatidine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Axid Ar

A generic version of AXID AR was approved as nizatidine by EPIC PHARMA LLC on July 5th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AXID AR?
  • What are the global sales for AXID AR?
  • What is Average Wholesale Price for AXID AR?
Summary for AXID AR
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 27
DailyMed Link:AXID AR at DailyMed
Drug patent expirations by year for AXID AR

US Patents and Regulatory Information for AXID AR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Haleon Us Holdings AXID AR nizatidine TABLET;ORAL 020555-001 May 9, 1996 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.